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ABSTRACT
FORMATION OF CLOT ANALOGS BETWEEN CO-FLOW FLUID STREAMS
IN A MICROCHANNEL DEVICE
by Sue-Mae Saw
Hemodynamics plays an important role in the formation of blood clots, for which
changes in hydrodynamic stresses and transport phenomena can initiate or inhibit the
clotting process. The fibrin network is highly influential in the structural mechanics of a
clot. This work demonstrated an ability to produce clot analogs at the boundary between
co-flow fluid streams, and investigated the dependence of clot shape and density
distribution on flow conditions. The time evolution of fibrin clots formed in
microchannel flow was investigated using fluorescence imaging. Clots were formed in a
polydimethylsiloxane (PDMS) microfluidic device which consisted of a Y-shaped
microchannel with two inlets and a single outlet. The clotting region had a cross-section
that was 300 µm wide and 12 µm deep. The first inlet introduced fresh frozen plasma
(FFP), while the second inlet introduced thrombin. Clot analogs were formed at the
interface of these two parallel streams at withdrawal flow rates of 100 nL/min, 200
nL/min, and 400 nL/min. These clots were shown to be insensitive to initial co-flow shear
rates, exhibiting similar clot shape and density distribution across the different flow rates.
Clots that are formed in such an engineered device provide opportunities to mimic in vivo
scenarios in which clot density and composition gradients depend on flow conditions.
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1. INTRODUCTION
1.1 Background
Clot analogs are important in biomedical research when developing physiologically
relevant models of vascular thrombosis and hemostasis. Unfortunately, existing studies
typically involve clots formed in a static environment with relatively homogeneous
composition, despite the composition of clinically relevant clots being very diverse with
variations in fibrin and red blood cell (RBC) composition [1]. Tissue factor (TF), exposed
at the sites of vascular injury, initiates the extrinsic coagulation cascade, ultimately
activating prothrombin into thrombin. Thrombin in turn converts fibrinogen to fibrin,
which is essential for the stabilization of a clot. Several in vitro studies have been
conducted to understand the effects of shear rate on blood coagulation initiated by TF or
thrombin, and these studies are mentioned in the following sections.
Microfluidic technology enables the manipulation of thrombus composition and
behavior through flow field and surface definition for clot initiation [2]. Complex flow
patterns induced by pulsatile motion, and rapid accelerations and decelerations can
similarly be introduced in microfluidic devices to imitate in vivo conditions [3].
Microfluidic devices are typically transparent, which enables visual observation and
monitoring of clotting behavior and progression.
1.1.1 Clot Formation and Structure
Virchow’s triad describes the three factors of thrombosis which are vessel wall injury,
changes in flow dynamics, and hypercoagulability due to blood being rich in clotting
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factors [3]–[5]. TF is exposed after vascular damage, ultimately resulting in thrombin
generation which is critical for the initiation of clotting. Analytical models,
computational studies and experimental investigations of the TF pathway have confirmed
that coagulation is triggered in a threshold manner, where an increase in TF binding sites
significantly changes the production of thrombin [6], [7].
Α blood clot comprises of a branched fibrin network, platelet aggregates and red
blood cells, with clot structure being influenced by blood flow forces and transport
mechanisms [8]. Mechanical behavior of clots depends heavily on the different
polymerization circumstances [9]. Depending on the conditions of fibrin formation, there
is variation in structural and mechanical properties of a clot [10]. Typical vasculature
shear rates are less than 200 s-1 in veins, greater than 500 s-1 in arteries, and between 1000
s-1 and 1800 s-1 in arterioles [2], [11], [12]. Engineered strain rate micro-gradients provide
a way of investigating platelet aggregation regulation [13]–[15]. Roessler et al. performed
in vitro coagulation at a larger scale for sonothrombolysis applications [16]. This work
was able to vary platelet count by altering flow conditions, eventually producing artificial
clots that achieved physiologically relevant histological characteristics.
Characterization of tissue can be conducted in vivo using pulse wave velocity, or ex
vivo methods [17]. Often, ex vivo mechanical studies on clots involve some form of
tensile testing [9], [18], or compression testing [9], [19]. There is a necessity to study the
interaction between clot mechanics and hemodynamics through the measurement of clot
mechanical properties while being formed under shear flow [20].
2

1.1.2 Coagulation and Flow Visualization
Coagulation is usually monitored using fluorescence microscopy with visual
detection of fluorescence-labeled thrombin generation, fibrin generation, and platelet
aggregation [21], [22]. Flow visualization enables direct observation of flow dynamics to
assist with better understanding and manipulation of coagulation in microfluidic devices.
Micron-resolution particle image velocimetry (μPIV) is a flow visualization technique
capable of measuring velocity fields at high temporal and spatial resolutions. The µPIV
system developed by Santiago et al. enables the characterization of performance in
micron-scale flow systems [23]. In μPIV, flow is seeded with fluorescent tracing
microparticles, and discrete images of particle distributions at two instances of time are
obtained. Flow velocity is deduced from the particle displacement in a two-dimensional
measurement plane within a given time interval. With the implementation of these
visualization techniques, the interaction between coagulation and flow dynamics can be
investigated.
1.2 Hypothesis
The hypothesis of this investigation is that clot density distribution and shape is
insensitive to initial co-flow shear rate.
The rationale for this hypothesis is that once a clot is formed at the co-flow boundary,
the dominant factors affecting clot growth are pressure difference across the clot and clot
permeability.
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1.3 Significance
Venous thromboembolism is life threatening, affecting up to 600,000 Americans
yearly [24]. Thrombus formation in vivo depends on many factors, and microfluidic
devices enable controlled manipulation of these factors to better understand the interplay
between prescribed conditions. Clot analogs are conventionally fabricated in a static in
vitro environment whereas clot formation in vivo occurs in the presence of dynamic
blood flow. Clot analogs are critical in studies involved in understanding the material and
mechanical properties of blood clots, benefiting the development of medical treatments
such as mechanical thrombectomy, stent angioplasty, and embolic filtration [25]. This
research seeks to synthesize realistic clot analogs at the boundary between active co-flow
fluid streams, with the ability to visualize and quantify the effects of flow dynamics on
the formation of clot analogs. These clot analogs will better mimic clots found in the
human body, assisting with future research concerned with the mechanical properties of
human blood clots.
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2. RELATED WORK
2.1 Microfluidic Coagulation
Through the observation of human blood and plasma flowing in silica capillaries
surface-patterned with patches of TF, the initiation of coagulation has been found to
depend on shear rate, and not volumetric flow rate or flow velocity [21]. Coagulation has
been seen to have a threshold response to shear rate and size of TF surface patch, where a
critical concentration of activated factors is required for the onset of clotting [7]. Hence, a
critical surface concentration of TF is required to trigger coagulation under flow, where
TF functions at a narrow range between 2 molecules-TF/μm2 and 20 molecules-TF/μm2
to initiate platelet and fibrin deposition on collagen at venous shear rates (100 s-1) and
arterial shear rates (500 s-1 or 1000 s-1). It is similarly recognized that spatial and temporal
growth, structure, and mechanical properties of a thrombus are TF surface area and
density dependent [26]. The circulation of TF in the flowing blood stream has also been
observed to play a contributing role in the propagation of thrombosis [27].
The influence of transport mechanisms on fibrin formation has been observed through
a two-channeled membrane-microfluidic device [28]. This device regulated fibrin fiber
deposition through thrombin flux and wall shear rate, where fibrin morphology was
described in terms of the Peclet and Damkohler numbers. Simultaneous experiments have
been conducted in an eight-channel microfluidic device under two modes of operation:
constant flow rate or pressure relief conditions, to study the role of fibrin in clot stability
[29]. The investigation of blood clot growth, stability and embolization for venous and
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arterial shear rates established that clot strength increased up to 28-fold with the presence
of fibrin, and 2-fold more fibrin formed under pressure relief mode in venous flow.
2.2 Characterization of Coagulation and Clots
As mentioned in Section 1.1.2, coagulation can be monitored with the assistance of
fluorescence microscopy. Fluorescence intensities of fibrin and platelets have been used
to quantify the height of clots [26], [29]. The decrease in fluorescence intensity and loss
in surface coverage of fluorescently labeled platelets have been correlated with the
decrease in clot stability [30]. Apart from extracting intensity values from captured
images, fibrin fiber diameter, branches and branching point densities can be determined
to characterize changes in fibrin morphology [31].
Besides visual supervision of thrombosis, immunoassays of effluents for prothrombin
fragment 1.2, thrombin-antithrombin complex and post-end point plasmin digest from
microfluidic thrombosis function as proxies to quantify the transient mass balance of
generated thrombin molecules and fibrin monomers in thrombosis [22]. As another
option, coagulation can be monitored with an acoustic sensor where resonant frequency
measurements decrease as clotting progresses [32]. It is possible to determine the
hydraulic permeability of the fibrin network via measurement of interstitial fluid flow
within clots at prescribed pressure gradients [33]. Platelet aggregate sizes ascertained
through image analysis of fluorescently labeled platelets, and fibrin fiber radii measured
by scanning electron microscopy, facilitate permeability computations. Clot permeability
has been found to vary by up to five orders of magnitude.
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There are various techniques available to determine the mechanical parameters of
microtissue through tensile testing. Using a magnetic bead microrheometer, a
particle-tracking microrheology technique studied the viscoelastic properties of human
fibrin and plasma clots [34]. Three stress relaxation mechanisms of fibrin were observed,
and the presence of factor XIII, the effect of fibrinogen, thrombin and calcium
concentration levels and the role of fibrinogen

on the viscoelastic behavior of clots

were investigated using this technique. Laser tweezers particle-tracking microrheology
paired with confocal reflection imaging have similarly been used to characterize fibrin
hydrogel [35]. Alternatively, the mechanical properties of fibrin networks have been
acquired using atomic force microscopy to stretch individual fibrin fibers, and with the
assistance of fluorescence microscopy, tensile strain was measured [36]. Tensile testing
of microtissues with magnetically actuated microcantilevers has enabled the uncoupled
study of cell and matrix effects on the mechanical properties of fibroblast-populated
collagen microtissues [37]. A recent work by Chen et al. integrates an elastometry system
within a microfluidic device, enabling real-time measurement of clot contraction and clot
stiffness as clotting happens under flow conditions [20].
2.3 Co-Flow and Gradient Generating Microfluidic Devices
The capability to precisely achieve and maintain control of in vitro m
 icrofluidic
generated chemical and concentration gradients benefits experiments that mimic
non-homogeneities occurring in vivo. Gradients can be achieved in a simple two-inlet
microchannel or a micromixer array of serpentine channels with each serpentine channel

7

serving as a diffusion mixing zone within a compact structure [38]. Jeon et al.
accomplished two types of gradients using a branched network of serpentine channels,
with the first type being solution composition gradients, and the second being surface
topography gradients of etch profiles on a silicon dioxide substrate [39]. This branched
network design has been further enhanced to involve controlled manipulation of gradients
with a range of complex shapes, including linear, parabolic and periodic shapes [40].
Parallel dividers to the direction of flow restrict interdiffusion between two adjacent
streams with distinct concentrations, and can be used for the control of gradient
generation [41]. With these dividers, any changes in gradient requirements can be
accommodated by repositioning the dividers within the channel.
Spatial control of three-dimensional concentration profiles of co-flowing streams has
been demonstrated in collagen-filled microchannels with multiple inlets [42].
Microchannel devices with similarly configured co-flow design involving two distinct
fluids have been engineered to study the transport and separation of microparticles across
laminar flow streams [43], [44]. Making use of three-dimensional particle-tracking
techniques and surface reconstruction algorithms, the interface at the co-flow boundary
can be reconstructed to assist with research dealing with micromixers [45].
Ability to introduce, modify, and observe constituents within fluid flow expands
investigative capability beyond surface-patterned approaches. For instance, Muthard and
Diamond performed assays of platelet function in a trifurcated microfluidic device by
controlling the interface between citrated whole blood and calcium-containing buffer,
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while also removing the corner effects of rectangular microfluidic devices [46].
Limitations of current microfluidic designs for coagulation research are the rectangular
channels which have large surface-to-volume ratio, and the edges of rectangular walls
which produce flow that are unlike flow within a cylindrical vascular tube [3]. Co-flow
fluid infusion also exists as a flow focusing technique. Onasoga-Jarvis et al. used a flow
focusing microchannel device consisting of three inlets to focus plasma flow over
TF-coated silica beads [47]. Through this device, it was concluded that fibrin deposition
depended on a threshold spot size and TF concentration, which in turn depended on shear
rate.
A gradient generating microfluidic device provides a platform to study the response
of cells to variation in concentration gradients. A microchannel device with three inlets
and 22 outlets has been used for bacterial chemotaxis [48]. The response of cells to
changes in solutions and concentrations was characterized by the count of accumulated
cells in each of the outlet ports. Using a two-channeled membrane-microfluidic device,
Kim et al. investigated the activation of Wnt/b-catenin signaling of HeLa cells, which
was made possible by a gradient generation chamber consisting of serpentine channels to
provide a bipolar environment [49]. This work successfully demonstrated the ability to
manipulate stable gradients, while also investigating diffusion- and convection-based
flow modes.
Another form of microfluidic gradient involves shear micro-gradients. Primarily shear
deceleration has been observed to be critical in the initiation of clotting through platelet
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aggregation, both in vivo and in vitro. This is true even in the absence of clotting factors
adenosine diphosphate, thromboxane A2, and thrombin [15]. Likewise, the criticality of
decelerating flow in coagulation activation has been seen in a microfluidic device which
mimicked a stenosed arteriole network [14].
2.4 Micron-resolution Particle Image Velocimetry (µPIV) in Blood
Velocity profiles of blood flow in rectangular polydimethylsiloxane (PDMS)
channels can be reliably interrogated via µPIV [50]–[52]. The effects of alginate as a
viscosity modifier on the behavior of porcine blood proved to have minimal effects on the
maximum velocity and flow rate within the channel, however, changes in viscosity had a
notable effect of between 8% to 100% on wall shear rate [51]. Research on the link
between the velocity profile and blood viscosity variation caused by RBC dispersion,
aggregation, and deformation has been similarly conducted in vivo and ex vivo with the
aid of µPIV [53]. Image processing techniques coupled with µPIV enabled the
characterization of RBC aggregation based on shear rates obtained from velocity profile
measurements [52]. Decreasing shear rates paired with higher hematocrit levels were
seen to increase viscosity, hence establishing the shear-thinning behavior of blood.
Nevertheless, the increase in aggregation size did not result in a linear increase in the
viscosity of blood. The effects of hemodynamics in a stenosed microchannel on platelet
aggregation have been similarly visualized and investigated [54]. The implications of
dynamic interactions between blood flow through a deformable channel mimicking
vasculature wall conditions have been investigated via µPIV of RBCs and 1 µm
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fluorescent particles [55]. In this study, it was apparent that RBC velocities were
impacted by wall compliance.
µPIV has been adapted for in vivo applications permitting the measurement of
velocity distribution even within an arteriole in a rat mesentery [56]. An intravital
microscope and a high-speed digital video system were used to measure the velocity
fields of RBCs, showing a blunt velocity profile in single and straight arterioles.
Likewise, the velocity of unsteady blood flow in the beating heart of a chicken embryo
has been measured, and shear stress distributions were successfully established within
this complex flow geometry [57].
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3. THEORY AND SIMULATION
3.1 Fluid Mechanics
Viscous flow is observed in blood vessels, with Stokes flow being observed near the
wall, and Poiseuille flow being observed away from the wall [12]. The velocity profile in
the direction of flow, ux( y, z) for Poiseuille flow through a straight rectangular channel for
a single fluid is given by equation (3.1) [58], [59]. In this equation, h is the channel
height, Δp is the pressure drop across the channel, µ is the fluid dynamic viscosity and L
is the channel length. The xyz-coordinate system adopted by this work is illustrated in
Figure 3.1.

(3.1)

The initiation of the clotting process is sensitive to shear rate, with typical
physiological rates ranging from 20 s-1 to 1800 s-1 [11]. In vitro experiments have also
been conducted under supra-physiological flow conditions (8000 s-1) in order to test the
stability of platelet aggregates formed between shear rates of 100 s-1 to 1000 s-1 [30].
Blood is described as a non-Newtonian fluid; however, at shear rates greater than 100 s-1
blood behaves like a Newtonian fluid. When there are no RBCs present (i.e., 0%
hematocrit), plasma also exhibits Newtonian fluid behavior [60]. Shear rate,

across the

width of the channel is described by equation (3.2) [61].
(3.2)
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The device presented in this work achieves a localized shear zone at the boundary
between two flow streams with distinct density and viscosity, involving fresh frozen
plasma (FFP) and thrombin, as shown in Figure 3.1 [52]. FFP contains fibrinogen and
plasma proteins, while thrombin converts fibrinogen to fibrin. During the clotting
experiments, thrombin was diluted in phosphate buffered saline (PBS) to achieve a
concentration of 12.5 U/mL. Hence, the fluid properties of the thrombin stream were
assumed to be synonymous with the fluid properties of PBS.
The fluid properties are as follows: FFP density, ρ1 = 1025 kg⋅m-3 [62], FFP dynamic
viscosity, μ1 = 0.0015 Pa⋅s [63], PBS density, ρ2 = 1000 kg⋅m-3 , and PBS dynamic
viscosity, μ2 = 0.001 Pa⋅s. These differences in fluid properties between the two streams
result in two distinct velocities in parallel. A single syringe pump that withdraws the fluid
at the outlet enforces a constant average flow rate, even though there exists two
characteristic velocities in the two parallel streams.

Figure 3.1 Co-flow of FFP and thrombin with differing densities and viscosities.
The presence of distinct velocities in each stream has been reinforced using
micron-resolution particle image velocimetry (µPIV, TSI Incorporated, Shoreview,
Minnesota, USA). The initial µPIV system by Santiago et al. consisted of an
13

epifluorescent microscope, an intensified charge-coupled device (CCD) camera and
continuous illumination from a mercury lamp [23]. This combination of a continuous
light and a CCD camera is only suitable for low-velocity flow measurements, which
limits the approaching mean velocity to 35 μm/s [64]. Later on, Meinhart et al. improved
illumination by utilizing a double-pulsed Nd:YAG laser [65]. This setup is currently
known as the standard μPIV system. A similar setup to this standard µPIV system was
used for the µPIV measurements shown in Figure 3.2.
Figure 3.2 presents velocity maps for flow within Y-shaped microchannels at
withdrawal flow rates of 100 nL/min and 200 nL/min, respectively. In these maps, FFP
flowed along the upper half of the microchannel, and PBS flowed along the lower half of
the microchannel. For each measurement, both fluid streams were seeded with 1 µm red
fluorescent particles (R0100, Fisher Scientific, Waltham, Massachusetts, USA) at 0.05%
concentration. Pure PBS seeded with tracing particles was used at the second inlet to
prevent the formation of clots at the co-flow boundary. As expected, these measurements
indicate that the thrombin stream would flow at a higher average velocity compared to
the FFP stream. From the velocity maps for both flow rates of 100 nL/min and 200
nL/min, it is evident that the distinct average velocities for each fluid stream would result
in shearing forces at the boundary.

14

100 nL/min

200 nL/min

Figure 3.2 µPIV velocity maps.
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3.2 Co-Flow Simulation
Simulations were conducted using COMSOL Multiphysics (COMSOL, Inc.,
Burlington, Massachusetts, USA) to estimate the initial shear rates at the co-flow stream
boundaries for volumetric flow rates of 100 nL/min, 200 nL/min and 400 nL/min. All
simulations were conducted using a two-dimensional model of the microchannel in the
xy-plane, at z = 6 µm, to reduce computational loads. A shallow channel approximation
was applied to account for the effects of the channel ceiling and floor on fluid flow. A
drag term, acting as a body force, was included in the Navier–Stokes equation, as shown
in equation (3.3) [66], [67]. F represents any other external body forces acting on the
fluid, such as gravity. In these simulations, F amounted to zero. Steady-state and
incompressible creeping flow were assumed for all simulations.
(3.3)
The main purpose of these simulations was to predict velocity and shear rate profiles,
hence the consideration of the diffusion of species was deemed unnecessary to include
within the simulation model. Figure 3.3 shows the fully-developed velocity profile across
the microchannel width at z = 6 µm, with FFP flowing along the upper half and thrombin
flowing along the lower half of the channel. The presence of distinct velocities is in
agreement with the µPIV velocity maps shown in Figure 3.2, along with the theoretical
solution and experimental µPIV observations reported by Pitts et al. [68].
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Figure 3.3 Simulated velocity profile across microchannel width at z = 6 µm.
As anticipated, the simulated shear rate is highest at the wall (assuming no-slip
condition), as shown in Figure 3.4. There is also a local peak at the interface between
fluids. Clot formation was not observed at the channel walls, but was only seen to form at
the boundary between the fluid streams where FFP and thrombin met. These simulated
results suggest that physiological initial shear rates can be achieved at the fluid interface.
Initial shear rates at the stream boundary at z = 6 µm for flow rates of 100 nL/min, 200
nL/min, and 400 nL/min are predicted to be 22.6 s-1, 45.2 s-1, and 90.4 s-1, respectively. It
is noted that this model only predicts the initial shear rate at the co-flow boundary. As the
clot forms at the boundary, the constant flow rate imposed by the syringe pump subjects
the growing clot with increasing shear rates on the surface of the clot [29].
Figure 3.5 shows the pressures across the width of the channel at x = 300 µm and z =
6 µm for withdrawal flow rates of 100 nL/min, 200 nL/min, and 400 nL/min. The
pressure differences at various width intervals for all three flow rates, in the y-direction,
are shown in Table 3.1.
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Figure 3.4 Simulated shear rate across microchannel width at z = 6 µm.

100 nL/min

200 nL/min

400 nL/min

Figure 3.5 Simulated pressure across microchannel width at x = 300 µm, z = 6 µm.
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Table 3.1 Pressure Differences Across Microchannel Width at x =300 µm, z = 6 µm
Flow Rate
(nL/min)

Pressure Difference (mPa)

y = -50 µm to 50 µm

y = -30 µm to 30 µm

y = -10 µm to 10 µm

200

0.21

0.26

0.12

400

0.42

0.51

0.23

100

0.10

0.13

0.06

It is observed that as the interval in the y-direction (e.g., y = -10 µm to 10 µm)
converges on the co-flow boundary, the distinction of the pressure difference values
decreases between the three flow rates. Hence, as the clot initially forms at the co-flow
boundary, it is predicted that the pressure difference across the clot (y- direction) is similar
for flow rates between 100 nL/min and 400 nL/min.
3.3 Clot Permeability
A blood clot is essentially a porous medium, and permeability through the clot can be
determined from Darcy’s law, as shown in equation (3.4) [33]. ν is the interstitial fluid
velocity, k is permeability, µ is the fluid dynamic viscosity and ∇p is the pressure
gradient vector.
(3.4)
Numerous relationships between permeability in fibrous media have been developed,
and have the general form shown in equation (3.5) [33]. af is the hydrated fibrin fiber
radius, and 𝜙f  is the fibrin fiber volume fraction.
(3.5)
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Equations 3.4 and 3.5 show that permeability is impacted by the pressure gradient
across the clot and permeability is also a function of fibrin density.
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4. METHODOLOGY
4.1 Material Selection, Device Design, and Fabrication
4.1.1 Blood and Material Selection
FFP and thrombin were flowed through a microchannel at room temperature.
Aliquots of FFP (Stanford Blood Center, Palo Alto, California, USA) and commercially
available thrombin (Catalog Number 69671, MilliporeSigma, Burlington, Massachusetts,
USA) were stored at -20 ºC and defrosted at room temperature. Thrombin with
concentration of 25 U/mL was diluted with 1X PBS (Gibco 20012050, Fisher Scientific,
Waltham, Massachusetts, USA) to achieve a concentration of 12.5 U/mL. To assist with
the visualization of fibrin clots, FFP was doped with 5% Alexa Fluor 594-conjugated
fibrinogen (F13193, Invitrogen, Waltham, Massachusetts, USA).
4.1.2 Device Design and Fabrication
The formation of clots between co-flow fluid streams requires a Y-channel device,
permitting the introduction of FFP and thrombin through separate inlets, to trigger an
onset of clotting when the two streams meet. The device must be optically transparent for
the visualization of clot formation with an inverted fluorescence microscope. The
microchannel design, consisting of a channel 300 µm wide, 12 µm deep, and 10 mm
long, is shown in Figure 4.1. FFP was introduced through the top inlet and thrombin was
introduced through the bottom inlet.
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Figure 4.1. Top-view of microfluidic device design.
Soft lithography and PDMS casting techniques, as in [69], were used to fabricate
single-use microfluidic devices. SU-8 2007 negative photoresist (MicroChem Corp.,
Westborough, Massachusetts, USA) was used to fabricate the master mold by selective
UV exposure. PDMS was cast on top of the master mold by first mixing and degassing a
10:1 mass ratio of PDMS base resin to curing agent (Sylgard 184, Dow Corning Corp.,
Midland, Michigan, USA), and then pouring the mixture on top of the master mold to be
cured on a hot plate at 100 ºC for 35 min. The outlet port was cored using a 1 mm
sampling tool (Harris Uni Core, Electron Microscopy Sciences, Hatfield, Pennsylvania,
USA). Inlet ports were cored using a larger 14-gauge stainless steel syringe needle tip to
create inlet reservoirs for reagents that were pipetted directly on to the device. The cored
PDMS was then plasma-bonded to a glass microscope slide in an inductively-coupled
plasma chamber (model PDC-001, Harrick Plasma, Ithaca, New York, USA) at pressures
between 300 mTorr to 500 mmTorr, 10 W power, for 60 s. The plasma-bonded chip was
annealed on a hot plate at 120 °C for 20 min, then left to cool to ambient temperature.
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4.2 Experimentation
4.2.1. Experimental Test Conditions
A total of six experiments were conducted with two replicates at each constant
withdrawal flow rate of 100 nL/min, 200 nL/min and 400 nL/min. Before attempting to
initiate clotting at the co-flow boundary, PBS was manually withdrawn from both inlets
by a manual syringe connected to the outlet port. The microchannel was manually primed
to remove any possible air bubbles and debris within the channel. Five µL of pure FFP
and 5 µL of pure PBS were then pipetted into each inlet well, and the syringe pump was
set to withdraw at 10 µL/min for 1 min. This preparatory step was intended to aid with
rapid removal of any hydraulic capacitance within the system, and also to reduce saline
dilution from PBS residue left behind by the previous manual withdraw step. The syringe
pump was then switched to withdraw at the required flow rate (i.e., 100 nL/min, 200
nL/min, or 400 nL/min) for 10 min to stabilize the flow rate.
After the flow rate had been allowed to stabilize, 10 µL of fluorescently labeled FFP
and thrombin, respectively, were pipetted into the inlets alternately at 5 µL increments.
Small increments were necessary to reduce unbalanced inlet pressures as a result of
differing static heights and droplet size. Immediately after thrombin was introduced into
the system, image acquisition of fibrin formation between the co-flow fluid streams
commenced. Clots were left to form at a constant withdrawal flow rate for a duration of
20 min.
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4.2.2 Apparatus and Measurement System
The experimental setup, shown in Figure 4.2, comprised a microfluidic device, an
inverted fluorescence microscope (DMi8, Leica Microsystems, Wetzlar, Germany), and
an sCMOS camera (Neo 5.5, Andor, Belfast, Northern Ireland). The outlet fluidic
connection was made by inserting an 18-gauge, 90º syringe needle tip into the pre-cored
outlet port. FFP and thrombin solutions were withdrawn through the channel by a syringe
pump (KDS Legato 111, KD Scientific, Holliston, Massachusetts, USA), which was
connected to the single outlet of the microchannel.
A three-way valve at the outlet provided the option of withdrawing fluid through the
channel with a manual syringe. PBS was first withdrawn into the channel with a manual
syringe, and flow to the syringe pump was shut off by the three-way valve. After
ensuring that the channel had been filled without any trapped air bubbles or debris, the
manual syringe was disengaged to allow pressures at the inlets and outlet to be at an
equilibrium. The three-way valve was then manipulated to enable automatic fluid
withdrawal by the syringe pump, closing off the fluidic connection to the manual syringe.
The syringe pump was placed at the same height as the microscope stage to avoid any
backflow induced by any difference in static heights between the inlets and the outlet.
Imaging of fluorescently labeled fibrin formation during coagulation was achieved
through the camera which was connected to the inverted fluorescence microscope. Image
analysis was conducted on the acquired images as a means of characterizing the clots.
Image analysis methods and clot characterization are discussed in Section 4.3.
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Figure 4.2 Flow testing apparatus.
4.2.4 Sources of Uncertainty
During each experimental run, flow instability is the main source of uncertainty. One
of the causes of this instability has been observed to be induced by unbalanced inlet
conditions. Flow instability here refers to oscillating movement of the boundary between
the two flow streams. Reagents in the inlet wells formed droplets at the top of the wells.
Differing droplet radii and static heights would cause unbalanced inlet pressures. The
distinct densities of each inlet reagent would cause the droplets at the inlets to diminish at
different rates, further causing unbalance of inlet driving forces between the two streams.
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Flow stability could also be hindered by compliance within the system as a result of
flexible tubing, flexible PDMS channel walls, and air bubbles on the order of 100 µm in
diameter within the system [61]. In this instance, flow instability is concerned with
varying flow rates within a particular experimental run. Often, protein clusters emerged
within the FFP fluid stream, contributing to unwanted obstructions within the
microchannel. At the onset of clotting, it was also likely that the flow rate had not
stabilized to be at the desired flow rate.
Variation in channel dimensions caused by fabrication deviations and PDMS
deformability would have effects on the flow rate. Hence, the initial shear rate at the
co-flow stream boundaries would be affected by deviations in microchannel dimensions.
Any height difference between the microchannel device and syringe pump would
similarly affect the flow rate. A less significant source of flow rate uncertainty was from
the syringe pump with a known accuracy of ± 0.5%.
To avoid unregulated clotting at transient flow rates, priming was initiated with PBS.
This initial step, however, introduced uncertainties in the reagent concentrations caused
by dilution of FFP and thrombin in PBS. Table 4.1 provides the estimated values for
some of the mentioned sources of experimental uncertainty.
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Table 4.1 Sources of Experimental Uncertainty
Source
FFP concentration

Nominal

Uncertainty

Notes

1.025 g/mL

− 0.2 g/mL Caused by PBS dilution

Thrombin concentration 12.5 U/mL

− 2.5 U/mL Caused by PBS dilution

Microchannel height

12 µm

± 1 µm

Caused by fabrication deviations and PDMS
deformability

Microchannel width

300 µm

±10 µm

Caused by fabrication deviations and PDMS
deformability

Syringe pump

100 nL/min ± 0.5 nL/min Caused by pump accuracy
200 nL/min ± 1.0 nL/min
400 nL/min ± 2.0 nL/min

4.3 Image Acquisition and Analysis
The monitoring of clot formation was conducted via fluorescent images of clots
acquired at one-minute intervals for a duration of 20 min, using the microscope interface
software (LAS X, Leica Microsystems, Buffalo Grove, Illinois, USA). Higher
fluorescence intensities indicate that a greater extent of crosslinking had occurred, hence
predicting a higher density of fibrin. All clot images were taken with exposure of 300 ms.
Brightfield images were obtained concurrently with fluorescent images of the fibrin clot
to assist with locating corresponding channel regions and walls. Once coagulation was
achieved within the channel, clot evolution was examined by stained fibrin microscope
images.
The field of view for the observation region is shown by the 415.84 µm ⨉ 350.84 µm
brightfield image in Figure 4.3, which was taken close to the inlet junction. All intensity
profile measurements were made 300 µm downstream from where the two streams first
meet, as indicated by the bold red line. Fluorescence intensities were extracted along this
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profile and analyzed using MATLAB (The MathWorks, Inc., Natick, Massachusetts,
USA).

Figure 4.3 Brightfield image of clot formation observation region in microchannel.
4.3.1 Measurement of Clot Density
Higher fluorescence intensities were correlated with higher fibrin densities within the
fibrin clot. Fluorescence has been observed to be difficult to calibrate, with fibrin
fluorescence varying up to ±50% coefficient of variation across human donors [22].
Therefore, intensity measurements were normalized by the maximum intensity measured
within each experimental run. Furthermore, normalized intensity values account for any
concentration discrepancies of Alexa Fluor 594-conjugated fibrinogen between runs,
caused by dilution from residue priming saline. The initial FFP stream was observed to
exhibit low-level fluorescence intensities, therefore, intensity measurements were
calibrated by removing this initial fluorescence measured at time 0 min. Uncalibrated and
calibrated normalized intensity measurements at 0 min, 10 min and 20 min for 100
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nL/min flow rate are shown in Figure 4.4. The time-tracking of maximum normalized
intensities provided a way to monitor clot growth.
Time (min)

Uncalibrated

Calibrated

0

10

20

Figure 4.4 Uncalibrated and calibrated normalized intensities at 100 nL/min flow rate.
4.3.2 Measurement of Clot Shape and Distribution
Clot shape was determined by the analysis of calibrated and normalized intensity
measurements at the base of the triangle measured at full-width, quarter-maximum
(FWQM) region of the intensity graphs [70]. For this analysis, the y-axis of the intensity
graphs were similarly normalized. As shown in Figure 4.5, a triangle was traced on the
FWQM region of the graph, and angles θ1, θ2, and θ3 were determined accordingly.
Equations (4.1) and (4.2) were used to characterize clot asymmetry and acuteness,
respectively from these three angles. An asymmetry value of one indicates perfect
symmetry, while acuteness increases with decreasing θ3 angle.
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Asymmetry

Acuteness

Figure 4.5 Clot shape analysis from intensity graphs.
(4.1)

(4.2)
Skewness and kurtosis were used to describe the clot density distribution in the
FWQM region. In order to investigate the effect of a coagulation inhibitor on the
formation of RBC aggregates, a similar time-tracking of skewness and kurtosis has been
performed, in search of temporal changes in ultrasound echo amplitudes [71]. This
approach has likewise been used to measure biofuel blending at the interface between
two distinct fluids in a microfluidic viscometer that had a similar Y-channel configuration
[72].
In this work, skewness, S and kurtosis, K for n values of a variable x were computed
according to the implementation in MATLAB, as shown in equations (4.3) and (4.4),
respectively. In this case, the variable x refers to the normalized clot intensity
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measurements. It is noted that an alternative definition of kurtosis subtracts 3 from this
kurtosis formula, such that a normal distribution would have a value of K = 0.

(4.3)

(4.4)

S = 0 corresponds to a symmetrical probability distribution, while positive values of
skewness refer to the mean and median of the clot density distribution being greater than
the mode of the distribution. Negative values of skewness correspond to the mean and
median being of lesser value than the mode.
K = 3 corresponds to a probability distribution having a kurtosis that is similar to a
normal distribution. For K > 3, the distribution has longer tails in comparison with a
normal distribution, while for K < 3, the tails are shorter.
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5. RESULTS AND DISCUSSION
The major results for clot analogs formation between co-flow fluid streams are
presented in this section. Clot formation was confirmed by fluorescence imaging of
fibrin. Clot density shape and density distribution characterization was achieved through
image analysis of the clots captured at one-minute intervals over a period of 20 min.
5.1 Clot Density
Figures 5.1, 5.2 and 5.3 present a condensed quantity of intensity images acquired at
10 min intervals, and the corresponding normalized fluorescence intensities measured
across the channel width at x = 300 µm (downstream of inlet junction). Two experimental
runs were conducted for each withdrawal flow rate of 100 nL/min, 200 nL/min, and 400
nL/min. The full range of fluorescence images taken at 1 min intervals and corresponding
intensity graphs are presented in Appendix A.
In addition to the primary peak in the fluorescence signal intensity, satellite peaks are
occasionally observed. A plausible explanation is that these satellite peaks are attributed
to changes in inlet pressure conditions due to unstable and unbalanced inlet conditions, as
discussed in Section 4.2.4. This instability results in a moving boundary between the
co-flow streams causing the continued formation of the clot to relocate in the y-direction.
Another possible cause for extra peaks is the change in FFP stream density, as the initial
priming fluid (i.e., PBS) is displaced by FFP, causing a lateral shift in the location where
clot formation occurs. High intensity spots or clusters visible in the fluorescence images
correspond to protein clusters found in FFP. Run 2 of flow rate 100 nL/min, Run 1 of
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flow rate 200 nL/min, and Run 2 of flow rate 400 nL/min contained more protein
clusters, as seen in Figures 5.1, 5.2, and 5.3. Since intensity measurements are only
analyzed at x = 300 µm, the effects of these protein clusters are most visible in the
intensity graphs of Run 2 of flow rate 400 nL/min (Figure 5.3). Within the field-of-view
of the camera for Run 2 of flow rate 400 nL/min, protein clusters are visible throughout
the top half of the channel, causing the corresponding intensity graphs to have multiple
peaks. It is observed that these protein clusters obstruct flow within the FFP stream,
pushing the clot to form in the lower section of the channel (negative y-direction).
Time
(min)

Run 1

Run 2

0

5

10

15

20

Figure 5.1 Clot intensities at 100 nL/min.
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Figure 5.2 Clot intensities at 200 nL/min.
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Figure 5.3 Clot intensities at 400 nL/min.
The time progression of normalized maximum intensities for each experimental run is
shown in Figure 5.4. Exponential curve fits using equation (5.1) were conducted on each
experimental run. The first-order exponential time constants, τ were extracted from these
curve fits and presented in Table 5.1.
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Legend:
𝗑 Run 1
o Run 2
100 nL/min

200 nL/min

400 nL/min

Figure 5.4 Time progression of normalized maximum intensities.
(5.1)
Table 5.1 First-Order Time Constants from Exponential Curve Fit
Flow Rate
(nL/min)
100
200
400

Run

Value

1

5.53

2

7.72

1

6.77

2

3.76

1

4.93

2

7.74

Time Constant, τ (min)

36

Average

Difference

6.62

2.19

5.23

3.01

6.34

2.82

Based on the time constants presented in Table 5.1, there is a difference of around 3
min between replicate runs. For all three flow rates, there is at least one run with visibly
more protein clusters, as shown by the high intensity patches in Run 2 of Figure 5.1, Run
1 of Figure 5.2, and Run 2 of Figure 5.3. The higher time constants in Table 5.1 seem to
correspond with the appearance of these protein clusters. Nevertheless, the time constant
averages for each flow rate show a lack of contrast, with a time constant total average of
around 6 min. This suggests that clot growth rate is consistent across the different flow
rates between 100 nL/min and 400 nL/min.
5.2 Clot Shape and Density Distribution
The time progression of clot asymmetry and acuteness obtained from the FWQM
region of the intensity graphs are presented in Figure 5.5. Connecting line segments in
Figure 5.5 are for visual tracing and not presented as a model fit. Table 5.2 reports the
final recorded asymmetry and acuteness measurements at the end of each experimental
run at 20 min.
The formed clots are mostly symmetrical, with asymmetry values being close to one.
This result conveys that clot growth rate in the opposite y-directions across the co-flow
boundary is close to being equal. With decreasing peak angles in the intensity graphs,
acuteness of the clot increases with time. The experimental runs containing more protein
clusters appear to have clots with higher acuteness at 20 min, which is probably a
consequence of the protein clusters restricting clot growth in the lateral direction of the
channel. Nonetheless, the final asymmetry and acuteness replicate averages at 20 min
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show that the final clot shape across the width of the channel is not influenced by the
withdrawal flow rate. The time progression of asymmetry values appears steady
throughout each experimental run, with asymmetry values between 0.9 and 1.0.
Acuteness, however, only achieves steady state (roughly 10% of the steady-state value)
after 15 min.
Asymmetry

Acuteness
Legend:
𝗑 Run 1
o Run 2

100
nL/min

200
nL/min

400
nL/min

Figure 5.5 Time progression of asymmetry and acuteness.
Table 5.2 Asymmetry and Acuteness at 20 Minutes
Flow Rate
Run
(nL/min)
100
200
400

Asymmetry
Value

1

0.986

2

0.957

1

0.936

2

0.930

1

0.972

2

0.950

Acuteness (°)

Average

Difference

0.971

0.029

0.933

0.007

0.961

0.023
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Value
15.34
12.63
12.29
15.33
18.69
11.53

Average

Difference

13.98

2.70

13.81

3.04

15.11

7.16

Skewness and kurtosis were used to describe the fluorescence intensity distribution as
a function of time. Similar to clot asymmetry and acuteness analyses, skewness and
kurtosis were determined for the datasets within the FWQM region of the intensity
measurements. Figure 5.6 presents the time evolution in skewness and kurtosis of clot
density distribution. Again, the connecting line segments in Figure 5.6 are for visual
tracing and not presented as a model fit. Table 5.3 reports the final recorded skewness
and kurtosis values at the end of each experimental run at 20 min.
Skewness

Kurtosis
Legend:
𝗑 Run 1
o Run 2

100
nL/min

200
nL/min

400
nL/min

Figure 5.6 Time progression of skewness and kurtosis.
Table 5.3 Skewness and Kurtosis at 20 Minutes
Flow Rate
Run
(nL/min)
100
200
400

Skewness
Value

1

0.678

2

-0.103

1

0.265

2

-0.308

1

0.200

2

1.155

Kurtosis

Average

Difference

0.288

0.782

0.022

0.573

0.678

0.955
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Value
2.338
1.463
1.520
1.456
1.421
3.037

Average

Difference

1.900

0.876

1.488

0.063

2.229

1.616

At 20 min, the skewness values for most experimental runs (except for Run 1 of 100
nL/min and Run 2 of 400 nL/min) trend toward zero value of skewness (between -0.5 and
0.5 skewness), indicating that the fibrin density distribution is close to a symmetrical
distribution. The fibrin density distribution of Run 1 of 100 nL/min and Run 2 of 400
nL/min at 20 min, however, are positively skewed at 0.678 and 1.155, respectively.
At 20 min, only Run 2 of 400 nL/min has a kurtosis value that is close to 3, meaning
that the kurtosis of the distribution is similar to the kurtosis of a normal distribution. The
remaining experimental runs have K < 3, meaning that the distribution has shorter tails,
with fewer and less extreme outliers than a normal distribution.
Skewness and kurtosis reach an approximately constant level after approximately 10
min. In the first few minutes after introduction of thrombin, the fibrin network structure
begins to develop. However, after approximately 10 min, the clot attains a stable density
distribution.
5.3 Flow Stability
Flow stability experiments were conducted with water being introduced at both inlets.
Food dye was added to one stream to assist with the visualization of the co-flow
boundary. Since both streams have identical fluid properties, it is expected for the
co-flow boundary to be precisely in the middle of the microchannel, in the y-direction.
Figure 5.7 presents images taken at 1 min intervals at withdrawal flow rate of 100
nL/min. Numbering within the images presents the sequence at which the images were
taken. These images demonstrate that flow was reasonably stable. This technique was
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used to adjust the experimental methodology accordingly, to assist with the control of
flow stability.

Figure 5.7 Monitoring flow stability at the co-flow boundary, at 1 min intervals.
5.4 Uncertainty Analysis
Surface profiler (Wyko NT9100, Bruker Corp., Tucson, AZ) measurements
conducted on multiple microchannel devices are shown in Table 5.4. Microchannel
cross-sectional height measurements show a standard deviation of 0.11 µm, while width
measurements have a standard deviation of 5.67 µm. These channel dimensions would
alter the velocity profile within the channel, as shown in equation (3.1). These deviations
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ultimately affect the accuracy of the estimated initial co-flow shear rates presented in
Section 3.2. Nevertheless, since clot growth rate, shape and distribution seem to be
independent of initial shear rate for the flow rate range of 100 nL/min to 400 nL/min,
these channel dimensional deviations are deemed to be acceptable.
Table 5.4 Surface Profiler Measurements of Microchannel Dimensions
Measurement

Height (µm)

Width (µm)

1

11.54

305.56

2

11.71

312.74

3

11.89

308.90

4

11.76

299.37

5

11.83

-

6

11.82

-

7

11.83

-

8

11.73

-

Standard Deviation

0.11

5.67
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6. CONCLUSIONS
A microfluidic device capable of fabricating fibrin clots between co-flow fluid
streams at physiological initial shear rates of 22.6 s-1, 45.2 s-1, and 90.4 s-1 was developed.
Fibrin clots were formed and imaged using fluorescence labeling of FFP paired with
fluorescence microscopy. Image analysis was used to quantify fibrin density, which was
highest where the FFP and thrombin streams initially met. Shape parameters were
developed, namely asymmetry and acuteness, to describe the shape of the clot in the
FWQM region of the intensity plot. Skewness and kurtosis were used to describe the
density distribution within the clot in the FWQM region.
Progression of intensities exhibited similar time constants across flow rates from 100
nL/min to 400 nL/min. From the clot shape and clot density distribution parameters, it
was observed that steady state was achieved within 15 min of each experimental run.
Formed clots exhibited similar growth rate, shape and distribution characteristics,
independent of flow rate and initial shear rate.
Distinct withdrawal flow rates dictated the initial shear rates at the co-flow boundary
(Figure 3.4) at which clotting was initiated. However, as clot size increased, shear rates
increased accordingly at the surface of the clot. From simulated pressure results (Figure
3.5), it was predicted that the pressure difference across the clot for the different flow
rates were similar. Clot permeability has been shown to be a function of fibrinogen
concentration [33], and since the same concentrations of FFP and thrombin were used for
all experiments, it is proposed that clots formed in all six experiments had similar
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permeability values. The results presented in Section 5 support the hypothesis that clot
shape and density distribution are insensitive to initial co-flow shear rate. Pressure
difference across the clot and clot permeability are predicted to be the dominant factors of
clot growth, shape, and density distribution.
Future work would involve altering substance concentration, design parameters (e.g.,
channel dimensions), substance combinations (e.g., whole blood and different clotting
factors), and operating conditions (e.g., pressure difference across clot and relative flow
rates) to engineer clot analogs with distinguishable shapes and density distributions.
Clinical specimens can be examined for blood clot composition and heterogeneity,
assisting with customizing the engineered device to manufacture accurate clot analogs.
Better control of initial co-flow shear rate and pressure difference across the clot can be
achieved pneumatically at the inlets by modifying the hydraulic resistance of inlet feeders
within the microfluidic device [73]. Flow control could also be improved by exploring
other flow infusion or gravity feed methods.
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APPENDIX A: RAW EXPERIMENTAL IMAGES AND INTENSITY GRAPHS
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APPENDIX B: MATLAB CODE FOR IMAGE ANALYSIS
Extracting Intensity Data and Maximum Intensity Curve Fit
%pixel range for profile locations
loc_x=([2166 333; 2173 340; 2233 400; 2168 335; 1986 153; 1953 120]);
%297.72 µm length
loc_y=([1900 1900; 1928 1928; 1888 1888; 1892 1892; 1972 1972; 1925
1925]); %at 300 µm from inlet
t0=[0 1 0 0 1 1]; %starting time in minutes
duration=20; %in minutes
d=dir('*.tif'); %importing all tif files
%graph plot dimensions
figure_height = 256;
figure_width = 4*figure_height/3; %set aspect ratio
font_size = figure_height/24; %scale text proportionally
% set scale
scale = 415.84/2560; %pixels in µm for 40X objective
for i=1:numel(d) %working through the different stacks
%extracting intensity profiles from a stack of images
fname=d(i).name;
info = imfinfo(fname);
num_images = numel(info); %number of images in the stack
%insert line location for intensity profile
x = loc_x(i,:);
y = loc_y(i,:);
for k = t0(i)+1:(t0(i)+duration+1) %images within the stack
I = imread(fname, k);
[cx,cy,YofIntensity]=improfile(I,x,y);
if k == t0(i)+1
intensity_0 = YofIntensity;
end
intensity(:,k-t0(i),i)=YofIntensity-intensity_0; %calibrate
max_intensity(k-t0(i),i)=max(intensity(:,k-t0(i),i));
t(k-t0(i),i) = k-t0(i)-1;
end
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max_intensity_norm(:,i)=max_intensity(:,i)/max(max_intensity(:,i));%norma
lized by maximum intensity
end
%curve fit for maximum intensity
for i=1:numel(d)
y_max = max(max_intensity_norm(:,i));
x = t(:,i);
y = max_intensity_norm(:,i);
n = length(y);
model = @(c,x) c(1)*(1-exp(-c(2)*x));
c0 = [0,0.1]; % Seed value.
[c,resnorm] = lsqcurvefit(model,c0,x,y);
y_fit(:,i) = c(1)*(1-exp(-c(2)*x));
SSR = 0;
SST = 0;
t_c(i)=1/c(2) %time constant
y_avg = mean(y)
for j = 1:n
SSR = SSR + (y_fit(j)-y_avg)^2;
SST = SST + (y(j)-y_avg)^2;
end
r_squared = SSR/SST
text_string = sprintf('y = %.2f*(1-exp(-%.3f*x))\nR² = %.3f',
c(1),c(2),r_squared)
a(:,i)=c';
end

59

Extracting Shape Parameters
y_norm = -((cx-(min(cx)))*scale-150)/300; %normalizing width
n_start = 4; %there are no peaks in the first few minutes
cut=0.25; %intensity lower threshold
%graph plot dimensions
figure_height = 256/2;
figure_width = 4*256/3; %set aspect ratio
font_size = 256/24; %scale text proportionally
for i=1:numel(d)
intensity_norm(:,:,i)=intensity(:,:,i)/max(max_intensity(:,i));
%normalizing intensity
for j=n_start:duration+1 %finding locations of triangular points
[maxValue,Ind_max]=max(intensity_norm(:,j,i));
[minValue,Ind_1(j,i)] =
min(abs(intensity_norm(1:Ind_max-1,j,i)-cut));
[minValue_2,Ind_2(j,i)] =
min(abs(intensity_norm(Ind_max+1:length(y_norm),j,i)-cut));
Ind_2(j,i) = Ind_max+Ind_2(j,i);
del_int = max(intensity_norm(:,j,i))-cut;
del_y_1 = y_norm(Ind_max)-y_norm(Ind_1(j,i));
del_y_2 = y_norm(Ind_2(j,i))-y_norm(Ind_max);
acute(j-n_start+1,i)=atand(del_y_1/del_int)+atand(del_y_2/del_int); %in
degrees
theta_max=max([atand(del_int/del_y_1), atand(del_int/del_y_2)]);
theta_min=min([atand(del_int/del_y_1), atand(del_int/del_y_2)]);
asym(j-n_start+1,i)=theta_min/theta_max;
skew_cut(j-n_start+1,i)=skewness(intensity(Ind_1(j,i):Ind_2(j,i),j,i));
%calculating skewness on selected region
kurt_cut(j-n_start+1,i)=kurtosis(intensity(Ind_1(j,i):Ind_2(j,i),j,i));
%calculating kurtosis on selected region
end
end
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